Skip to main content
TipRanks
Go Ultimate75% OFF

Eastwood Bio-Medical Canada (EBM) Ratios

5 Followers

Eastwood Bio-Medical Canada Ratios

TSE:EBM's free cash flow for Q3 2026 was C$-1.17K. For the 2026 fiscal year, TSE:EBM's free cash flow was increased by C$4.00 and operating cash flow was C$-1.17K. See a summary of the company’s cash flow.

Financial ratios
RatiosJan 26Jan 25Oct 23Oct 22Jan 22
Liquidity Ratios
Current Ratio0.020.030.110.120.07
Quick Ratio0.020.030.110.120.07
Cash Ratio0.010.000.010.050.03
Solvency Ratio-0.16-0.22-0.33-0.06-0.61
Operating Cash Flow Ratio0.01-0.01-0.01-0.01-0.14
Short-Term Operating Cash Flow Coverage0.25-0.19-0.73-0.160.00
Net Current Asset ValueC$ -1.82MC$ -1.53MC$ -1.18MC$ -777.27KC$ -777.57K
Leverage Ratios
Debt-to-Assets Ratio0.360.290.050.110.05
Debt-to-Equity Ratio-0.05-0.06-0.03-0.21-0.22
Debt-to-Capital Ratio-0.05-0.07-0.03-0.27-0.28
Long-Term Debt-to-Capital Ratio0.000.000.00-0.13-0.28
Financial Leverage Ratio-0.13-0.21-0.58-1.99-4.79
Debt Service Coverage Ratio-3.56-3.98-8.01-1.13-180.50
Interest Coverage Ratio-39.38-69.63-17.97-12.03-211.94
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.000.000.000.00
Net Debt to EBITDA-0.19-0.23-0.01-0.69-0.02
Profitability Margins
Gross Profit Margin64.70%64.72%50.75%69.45%46.72%
EBIT Margin-45.35%-64.04%-59.73%-10.71%-61.24%
EBITDA Margin-39.60%-48.72%-47.31%-2.49%-50.51%
Operating Profit Margin-45.35%-62.34%-58.30%-9.91%-60.23%
Pretax Profit Margin-42.55%-64.93%-62.98%-11.53%-61.53%
Net Profit Margin-42.55%-64.93%-62.98%-12.35%-62.31%
Continuous Operations Profit Margin-42.55%-64.93%-62.98%-11.53%-61.53%
Net Income Per EBT100.00%100.00%100.00%107.14%101.28%
EBT Per EBIT93.82%104.15%108.01%116.40%102.15%
Return on Assets (ROA)-152.11%-166.20%-111.75%-27.47%-88.46%
Return on Equity (ROE)20.42%35.16%65.01%54.58%423.60%
Return on Capital Employed (ROCE)21.77%33.76%60.19%49.63%523.06%
Return on Invested Capital (ROIC)22.86%35.96%61.88%55.51%523.06%
Return on Tangible Assets-152.11%-166.20%-111.75%-27.47%-88.46%
Earnings Yield-0.69%-0.68%-0.99%-0.19%-0.61%
Efficiency Ratios
Receivables Turnover53.4916.3710.4889.09162.88
Payables Turnover3.273.284.206.589.86
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover4.213.042.572.911.78
Asset Turnover3.572.561.772.221.42
Working Capital Turnover Ratio-0.47-0.52-0.90-1.75-1.92
Cash Conversion Cycle-104.86-88.90-52.06-51.35-34.77
Days of Sales Outstanding6.8222.2934.824.102.24
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding111.68111.2086.8855.4537.01
Operating Cycle6.8222.2934.824.102.24
Cash Flow Ratios
Operating Cash Flow Per Share0.00-0.00-0.00-0.00-0.00
Free Cash Flow Per Share0.00-0.00-0.00-0.00-0.00
Dividend Paid and CapEx Coverage Ratio6434.330.00-8444.00-1.43-20.85
Capital Expenditure Coverage Ratio6434.330.00-8444.00-1.43-20.85
Operating Cash Flow Coverage Ratio0.25-0.19-0.73-0.07-3.71
Operating Cash Flow to Sales Ratio0.02-0.02-0.02-0.00-0.12
Free Cash Flow Yield0.04%-0.02%-0.03%-0.01%-0.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-145.83-148.09-100.82-536.21-164.51
Price-to-Sales (P/S) Ratio61.6696.1663.4966.25102.52
Price-to-Book (P/B) Ratio-29.59-52.06-65.54-292.69-696.88
Price-to-Free Cash Flow (P/FCF) Ratio2498.45-4436.37-3262.80-11797.16-825.81
Price-to-Operating Cash Flow Ratio2498.07-4436.37-3263.19-20052.97-865.42
Price-to-Earnings Growth (PEG) Ratio5.359.00-0.417.235.71
Enterprise Value Multiple-155.88-197.60-134.23-2664.25-202.99
Enterprise Value48.28M67.59M55.11M86.13M100.58M
EV to EBITDA-155.88-197.60-134.23-2664.25-202.99
EV to Sales61.7396.2763.5066.27102.53
EV to Free Cash Flow2501.58-4441.60-3263.08-11800.23-825.89
EV to Operating Cash Flow2501.19-4441.60-3263.47-20058.19-865.51
Tangible Book Value Per Share-0.02-0.02-0.01-0.00-0.00
Shareholders’ Equity Per Share-0.02-0.02-0.01-0.00-0.00
Tax and Other Ratios
Effective Tax Rate0.000.000.00-0.07-0.01
Revenue Per Share0.010.010.010.020.01
Net Income Per Share-0.00-0.01-0.01-0.00-0.01
Tax Burden1.001.001.001.071.01
Interest Burden0.941.011.051.081.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue1.100.750.770.710.97
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality-0.060.030.030.030.19

Currency in CAD